{
    "abstract": "Background: Palivizumab, a monoclonal antibody and the only licensed immunization product for preventing respiratory syncytial virus (RSV) infection, is recommended for children with certain high-risk conditions. Other antibody products and maternal vaccines targeting young infants are in clinical development. Few studies have compared products closest to potential licensure and have primarily focused on the effects on hospitalizations only. Estimates of the impact of these products on medically-attended (MA) infections in a variety of healthcare settings are needed to assist with developing RSV immunization recommendations. Methods: We developed a tool for practicing public health officials to estimate the impact of immunization strategies on RSV-associated MA lower respiratory tract infections (LRTIs) in various healthcare settings among infants <12 months. Users input RSV burden and seasonality and examine the influence of altering product efficacy and uptake assumptions. We used the tool to evaluate candidate products\u2019 impacts among a US birth cohort. Results: We estimated without immunization, 407,360 (range: 339,650\u2013475,980) LRTIs are attended annually in outpatient clinics, 147,240 (126,070\u2013168,510) in emergency departments (EDs), and 33,180 (24,760\u201342,900) in hospitals. A passive antibody candidate targeting all infants prevented the most LRTIs: 196,470 (48% of visits without immunization) outpatient clinic visits (range: 163,810\u2013229,650), 75,250 (51%) EDs visits (64,430\u201386,090), and 18,140 (55%) hospitalizations (13,770\u201323,160). A strategy combining maternal vaccine candidate and palivizumab prevented 58,210 (14% of visits without immunization) LRTIs in outpatient clinics (range: 48,520\u201367,970), 19,580 (13%) in EDs (16,760\u201322,400), and 8,190 (25%) hospitalizations (6,390\u201310,150). Conclusions: Results underscore the potential for anticipated products to reduce serious RSV illness. Our tool (provided to readers) can be used by different jurisdictions and accept updated data. Results can aid economic evaluations and public health decision-making regarding RSV immunization products.",
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Ting",
                    "initial": "T.",
                    "last": "Shi"
                },
                {
                    "first": "David A.",
                    "initial": "D.A.",
                    "last": "McAllister"
                },
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                },
                {
                    "first": "Eric A.F.",
                    "initial": "E.A.F.",
                    "last": "Simoes"
                },
                {
                    "first": "Shabir A.",
                    "initial": "S.A.",
                    "last": "Madhi"
                },
                {
                    "first": "Bradford D.",
                    "initial": "B.D.",
                    "last": "Gessner"
                },
                {
                    "first": "Fernando P.",
                    "initial": "F.P.",
                    "last": "Polack"
                },
                {
                    "first": "Evelyn",
                    "initial": "E.",
                    "last": "Balsells"
                },
                {
                    "first": "Sozinho",
                    "initial": "S.",
                    "last": "Acacio"
                },
                {
                    "first": "Claudia",
                    "initial": "C.",
                    "last": "Aguayo"
                },
                {
                    "first": "Issifou",
                    "initial": "I.",
                    "last": "Alassani"
                },
                {
                    "first": "Asad",
                    "initial": "A.",
                    "last": "Ali"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Antonio"
                },
                {
                    "first": "Shally",
                    "initial": "S.",
                    "last": "Awasthi"
                },
                {
                    "first": "Juliet O.",
                    "initial": "J.O.",
                    "last": "Awori"
                },
                {
                    "first": "Eduardo",
                    "initial": "E.",
                    "last": "Azziz-Baumgartner"
                },
                {
                    "first": "Henry C.",
                    "initial": "H.C.",
                    "last": "Baggett"
                },
                {
                    "first": "Vicky L.",
                    "initial": "V.L.",
                    "last": "Baillie"
                },
                {
                    "first": "Angel",
                    "initial": "A.",
                    "last": "Balmaseda"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Barahona"
                },
                {
                    "first": "Sudha",
                    "initial": "S.",
                    "last": "Basnet"
                },
                {
                    "first": "Quique",
                    "initial": "Q.",
                    "last": "Bassat"
                },
                {
                    "first": "Wilma",
                    "initial": "W.",
                    "last": "Basualdo"
                },
                {
                    "first": "Godfrey",
                    "initial": "G.",
                    "last": "Bigogo"
                },
                {
                    "first": "Louis",
                    "initial": "L.",
                    "last": "Bont"
                },
                {
                    "first": "Robert F.",
                    "initial": "R.F.",
                    "last": "Breiman"
                },
                {
                    "first": "W. Abdullah",
                    "initial": "W.A.",
                    "last": "Brooks"
                },
                {
                    "first": "Shobha",
                    "initial": "S.",
                    "last": "Broor"
                },
                {
                    "first": "Nigel",
                    "initial": "N.",
                    "last": "Bruce"
                },
                {
                    "first": "Dana",
                    "initial": "D.",
                    "last": "Bruden"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Buchy"
                },
                {
                    "first": "Stuart",
                    "initial": "S.",
                    "last": "Campbell"
                },
                {
                    "first": "Phyllis",
                    "initial": "P.",
                    "last": "Carosone-Link"
                },
                {
                    "first": "Mandeep",
                    "initial": "M.",
                    "last": "Chadha"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Chipeta"
                },
                {
                    "first": "Monidarin",
                    "initial": "M.",
                    "last": "Chou"
                },
                {
                    "first": "Wilfrido",
                    "initial": "W.",
                    "last": "Clara"
                },
                {
                    "first": "Cheryl",
                    "initial": "C.",
                    "last": "Cohen"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "de Cuellar"
                },
                {
                    "first": "Duc Anh",
                    "initial": "D.A.",
                    "last": "Dang"
                },
                {
                    "first": "Budragchaagiin",
                    "initial": "B.",
                    "last": "Dash-yandag"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Deloria-Knoll"
                },
                {
                    "first": "Mukesh",
                    "initial": "M.",
                    "last": "Dherani"
                },
                {
                    "first": "Tekchheng",
                    "initial": "T.",
                    "last": "Eap"
                },
                {
                    "first": "Bernard E.",
                    "initial": "B.E.",
                    "last": "Ebruke"
                },
                {
                    "first": "Marcela",
                    "initial": "M.",
                    "last": "Echavarria"
                },
                {
                    "first": "Carla Cec\u00edlia",
                    "initial": "C.C.",
                    "last": "de Freitas L\u00e1zaro Emediato"
                },
                {
                    "first": "Rodrigo A.",
                    "initial": "R.A.",
                    "last": "Fasce"
                },
                {
                    "first": "Daniel R.",
                    "initial": "D.R.",
                    "last": "Feikin"
                },
                {
                    "first": "Luzhao",
                    "initial": "L.",
                    "last": "Feng"
                },
                {
                    "first": "Angela",
                    "initial": "A.",
                    "last": "Gentile"
                },
                {
                    "first": "Aubree",
                    "initial": "A.",
                    "last": "Gordon"
                },
                {
                    "first": "Doli",
                    "initial": "D.",
                    "last": "Goswami"
                },
                {
                    "first": "Sophie",
                    "initial": "S.",
                    "last": "Goyet"
                },
                {
                    "first": "Michelle",
                    "initial": "M.",
                    "last": "Groome"
                },
                {
                    "first": "Natasha",
                    "initial": "N.",
                    "last": "Halasa"
                },
                {
                    "first": "Siddhivinayak",
                    "initial": "S.",
                    "last": "Hirve"
                },
                {
                    "first": "Nusrat",
                    "initial": "N.",
                    "last": "Homaira"
                },
                {
                    "first": "Stephen R.C.",
                    "initial": "S.R.C.",
                    "last": "Howie"
                },
                {
                    "first": "Jorge",
                    "initial": "J.",
                    "last": "Jara"
                },
                {
                    "first": "Imane",
                    "initial": "I.",
                    "last": "Jroundi"
                },
                {
                    "first": "Cissy B.",
                    "initial": "C.B.",
                    "last": "Kartasasmita"
                },
                {
                    "first": "Najwa",
                    "initial": "N.",
                    "last": "Khuri-Bulos"
                },
                {
                    "first": "Karen L.",
                    "initial": "K.L.",
                    "last": "Kotloff"
                },
                {
                    "first": "Anand",
                    "initial": "A.",
                    "last": "Krishnan"
                },
                {
                    "first": "Romina",
                    "initial": "R.",
                    "last": "Libster"
                },
                {
                    "first": "Olga",
                    "initial": "O.",
                    "last": "Lopez"
                },
                {
                    "first": "Marilla G.",
                    "initial": "M.G.",
                    "last": "Lucero"
                },
                {
                    "first": "Florencia",
                    "initial": "F.",
                    "last": "Lucion"
                },
                {
                    "first": "Socorro P.",
                    "initial": "S.P.",
                    "last": "Lupisan"
                },
                {
                    "first": "Debora N.",
                    "initial": "D.N.",
                    "last": "Marcone"
                },
                {
                    "first": "John P.",
                    "initial": "J.P.",
                    "last": "McCracken"
                },
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Mejia"
                },
                {
                    "first": "Jennifer C.",
                    "initial": "J.C.",
                    "last": "Moisi"
                },
                {
                    "first": "Joel M.",
                    "initial": "J.M.",
                    "last": "Montgomery"
                },
                {
                    "first": "David P.",
                    "initial": "D.P.",
                    "last": "Moore"
                },
                {
                    "first": "Cinta",
                    "initial": "C.",
                    "last": "Moraleda"
                },
                {
                    "first": "Jocelyn",
                    "initial": "J.",
                    "last": "Moyes"
                },
                {
                    "first": "Patrick",
                    "initial": "P.",
                    "last": "Munywoki"
                },
                {
                    "first": "Kuswandewi",
                    "initial": "K.",
                    "last": "Mutyara"
                },
                {
                    "first": "Mark P.",
                    "initial": "M.P.",
                    "last": "Nicol"
                },
                {
                    "first": "D. James",
                    "initial": "D.J.",
                    "last": "Nokes"
                },
                {
                    "first": "Pagbajabyn",
                    "initial": "P.",
                    "last": "Nymadawa"
                },
                {
                    "first": "Maria Tereza",
                    "initial": "M.T.",
                    "last": "da Costa Oliveira"
                },
                {
                    "first": "Histoshi",
                    "initial": "H.",
                    "last": "Oshitani"
                },
                {
                    "first": "Nitin",
                    "initial": "N.",
                    "last": "Pandey"
                },
                {
                    "first": "Gl\u00e1ucia",
                    "initial": "G.",
                    "last": "Paranhos-Baccal\u00e0"
                },
                {
                    "first": "Lia N.",
                    "initial": "L.N.",
                    "last": "Phillips"
                },
                {
                    "first": "Valentina Sanchez",
                    "initial": "V.S.",
                    "last": "Picot"
                },
                {
                    "first": "Mustafizur",
                    "initial": "M.",
                    "last": "Rahman"
                },
                {
                    "first": "Mala",
                    "initial": "M.",
                    "last": "Rakoto-Andrianarivelo"
                },
                {
                    "first": "Zeba A.",
                    "initial": "Z.A.",
                    "last": "Rasmussen"
                },
                {
                    "first": "Barbara A.",
                    "initial": "B.A.",
                    "last": "Rath"
                },
                {
                    "first": "Annick",
                    "initial": "A.",
                    "last": "Robinson"
                },
                {
                    "first": "Candice",
                    "initial": "C.",
                    "last": "Romero"
                },
                {
                    "first": "Graciela",
                    "initial": "G.",
                    "last": "Russomando"
                },
                {
                    "first": "Vahid",
                    "initial": "V.",
                    "last": "Salimi"
                },
                {
                    "first": "Pongpun",
                    "initial": "P.",
                    "last": "Sawatwong"
                },
                {
                    "first": "Nienke",
                    "initial": "N.",
                    "last": "Scheltema"
                },
                {
                    "first": "Brunhilde",
                    "initial": "B.",
                    "last": "Schweiger"
                },
                {
                    "first": "J. Anthony G.",
                    "initial": "J.A.G.",
                    "last": "Scott"
                },
                {
                    "first": "Phil",
                    "initial": "P.",
                    "last": "Seidenberg"
                },
                {
                    "first": "Kunling",
                    "initial": "K.",
                    "last": "Shen"
                },
                {
                    "first": "Rosalyn",
                    "initial": "R.",
                    "last": "Singleton"
                },
                {
                    "first": "Viviana",
                    "initial": "V.",
                    "last": "Sotomayor"
                },
                {
                    "first": "Tor A.",
                    "initial": "T.A.",
                    "last": "Strand"
                },
                {
                    "first": "Agustinus",
                    "initial": "A.",
                    "last": "Sutanto"
                },
                {
                    "first": "Mariam",
                    "initial": "M.",
                    "last": "Sylla"
                },
                {
                    "first": "Milagritos D.",
                    "initial": "M.D.",
                    "last": "Tapia"
                },
                {
                    "first": "Somsak",
                    "initial": "S.",
                    "last": "Thamthitiwat"
                },
                {
                    "first": "Elizabeth D.",
                    "initial": "E.D.",
                    "last": "Thomas"
                },
                {
                    "first": "Rafal",
                    "initial": "R.",
                    "last": "Tokarz"
                },
                {
                    "first": "Claudia",
                    "initial": "C.",
                    "last": "Turner"
                },
                {
                    "first": "Marietjie",
                    "initial": "M.",
                    "last": "Venter"
                },
                {
                    "first": "Sunthareeya",
                    "initial": "S.",
                    "last": "Waicharoen"
                },
                {
                    "first": "Jianwei",
                    "initial": "J.",
                    "last": "Wang"
                },
                {
                    "first": "Wanitda",
                    "initial": "W.",
                    "last": "Watthanaworawit"
                },
                {
                    "first": "Lay Myint",
                    "initial": "L.M.",
                    "last": "Yoshida"
                },
                {
                    "first": "Hongjie",
                    "initial": "H.",
                    "last": "Yu"
                },
                {
                    "first": "Heather J.",
                    "initial": "H.J.",
                    "last": "Zar"
                },
                {
                    "first": "Harry",
                    "initial": "H.",
                    "last": "Campbell"
                },
                {
                    "first": "Harish",
                    "initial": "H.",
                    "last": "Nair"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/S0140-6736(17)30938-8",
            "firstpage": "946",
            "issn": "01406736",
            "lastpage": "958",
            "pmid": "28689664",
            "pub_year": 2017,
            "title": "Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study",
            "volume": "390"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Caroline Breese",
                    "initial": "C.B.",
                    "last": "Hall"
                },
                {
                    "first": "Geoffrey A.",
                    "initial": "G.A.",
                    "last": "Weinberg"
                },
                {
                    "first": "Marika K.",
                    "initial": "M.K.",
                    "last": "Iwane"
                },
                {
                    "first": "Aaron K.",
                    "initial": "A.K.",
                    "last": "Blumkin"
                },
                {
                    "first": "Kathryn M.",
                    "initial": "K.M.",
                    "last": "Edwards"
                },
                {
                    "first": "Mary A.",
                    "initial": "M.A.",
                    "last": "Staat"
                },
                {
                    "first": "Peggy",
                    "initial": "P.",
                    "last": "Auinger"
                },
                {
                    "first": "Marie R.",
                    "initial": "M.R.",
                    "last": "Griffin"
                },
                {
                    "first": "Katherine A.",
                    "initial": "K.A.",
                    "last": "Poehling"
                },
                {
                    "first": "Dean",
                    "initial": "D.",
                    "last": "Erdman"
                },
                {
                    "first": "Carlos G.",
                    "initial": "C.G.",
                    "last": "Grijalva"
                },
                {
                    "first": "Yuwei",
                    "initial": "Y.",
                    "last": "Zhu"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Szilagyi"
                }
            ],
            "doi": "10.1056/NEJMoa0804877",
            "firstpage": "588",
            "issn": "00284793",
            "lastpage": "598",
            "pmid": "19196675",
            "pub_year": 2009,
            "title": "The Burden of respiratory syncytial virus infection in young children",
            "volume": "360"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Carrie L.",
                    "initial": "C.L.",
                    "last": "Byington"
                },
                {
                    "first": "Jacob",
                    "initial": "J.",
                    "last": "Wilkes"
                },
                {
                    "first": "Kent",
                    "initial": "K.",
                    "last": "Korgenski"
                },
                {
                    "first": "Xiaoming",
                    "initial": "X.",
                    "last": "Sheng"
                }
            ],
            "doi": "10.1542/peds.2014-2151",
            "firstpage": "e24",
            "issn": "00314005",
            "lastpage": "e31",
            "pmid": "25489019",
            "pub_year": 2015,
            "title": "Respiratory syncytial virus-associated mortality in hospitalized infants and young children",
            "volume": "135"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Caroline Breese",
                    "initial": "C.B.",
                    "last": "Hall"
                },
                {
                    "first": "Geoffrey A.",
                    "initial": "G.A.",
                    "last": "Weinberg"
                },
                {
                    "first": "Aaron K.",
                    "initial": "A.K.",
                    "last": "Blumkin"
                },
                {
                    "first": "Kathryn M.",
                    "initial": "K.M.",
                    "last": "Edwards"
                },
                {
                    "first": "Mary A.",
                    "initial": "M.A.",
                    "last": "Staat"
                },
                {
                    "first": "Andrew F.",
                    "initial": "A.F.",
                    "last": "Schultz"
                },
                {
                    "first": "Katherine A.",
                    "initial": "K.A.",
                    "last": "Poehling"
                },
                {
                    "first": "Peter G.",
                    "initial": "P.G.",
                    "last": "Szilagyi"
                },
                {
                    "first": "Marie R.",
                    "initial": "M.R.",
                    "last": "Griffin"
                },
                {
                    "first": "John V.",
                    "initial": "J.V.",
                    "last": "Williams"
                },
                {
                    "first": "Yuwei",
                    "initial": "Y.",
                    "last": "Zhu"
                },
                {
                    "first": "Carlos G.",
                    "initial": "C.G.",
                    "last": "Grijalva"
                },
                {
                    "first": "Mila M.",
                    "initial": "M.M.",
                    "last": "Prill"
                },
                {
                    "first": "Marika K.",
                    "initial": "M.K.",
                    "last": "Iwane"
                }
            ],
            "doi": "10.1542/peds.2013-0303",
            "firstpage": "e341",
            "issn": "00314005",
            "lastpage": "e348",
            "pmid": "23878043",
            "pub_year": 2013,
            "title": "Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age",
            "volume": "132"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Joana Y.",
                    "initial": "J.Y.",
                    "last": "Lively"
                },
                {
                    "first": "Aaron T.",
                    "initial": "A.T.",
                    "last": "Curns"
                },
                {
                    "first": "Geoffrey A.",
                    "initial": "G.A.",
                    "last": "Weinberg"
                },
                {
                    "first": "Kathryn M.",
                    "initial": "K.M.",
                    "last": "Edwards"
                },
                {
                    "first": "Mary A.",
                    "initial": "M.A.",
                    "last": "Staat"
                },
                {
                    "first": "Mila M.",
                    "initial": "M.M.",
                    "last": "Prill"
                },
                {
                    "first": "Susan I.",
                    "initial": "S.I.",
                    "last": "Gerber"
                },
                {
                    "first": "Gayle E.",
                    "initial": "G.E.",
                    "last": "Langley"
                }
            ],
            "doi": "10.1093/jpids/piz011",
            "firstpage": "284",
            "issn": "20487193",
            "lastpage": "286",
            "pmid": "30840770",
            "pub_year": 2019,
            "title": "Respiratory syncytial virus-associated outpatient visits among childrenyoungerthan 24 months",
            "volume": "8"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Erica Billig",
                    "initial": "E.B.",
                    "last": "Rose"
                },
                {
                    "first": "Alexandra",
                    "initial": "A.",
                    "last": "Wheatley"
                },
                {
                    "first": "Gayle",
                    "initial": "G.",
                    "last": "Langley"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Gerber"
                },
                {
                    "first": "Amber",
                    "initial": "A.",
                    "last": "Haynes"
                }
            ],
            "doi": "10.15585/mmwr.mm6702a4",
            "firstpage": "71",
            "issn": "01492195",
            "lastpage": "76",
            "pmid": "29346336",
            "pub_year": 2018,
            "title": "Respiratory syncytial virus seasonality \u2014 United States, 2014\u20132017",
            "volume": "67"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Amber K.",
                    "initial": "A.K.",
                    "last": "Haynes"
                },
                {
                    "first": "Arie P.",
                    "initial": "A.P.",
                    "last": "Manangan"
                },
                {
                    "first": "Marika K.",
                    "initial": "M.K.",
                    "last": "Iwane"
                },
                {
                    "first": "Katharine",
                    "initial": "K.",
                    "last": "Sturm-Ramirez"
                },
                {
                    "first": "Nusrat",
                    "initial": "N.",
                    "last": "Homaira"
                },
                {
                    "first": "W. Abdullah",
                    "initial": "W.A.",
                    "last": "Brooks"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Luby"
                },
                {
                    "first": "Mahmudur",
                    "initial": "M.",
                    "last": "Rahman"
                },
                {
                    "first": "John D.",
                    "initial": "J.D.",
                    "last": "Klena"
                },
                {
                    "first": "Yuzhi",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Hongie",
                    "initial": "H.",
                    "last": "Yu"
                },
                {
                    "first": "Faxian",
                    "initial": "F.",
                    "last": "Zhan"
                },
                {
                    "first": "Erica",
                    "initial": "E.",
                    "last": "Dueger"
                },
                {
                    "first": "Adel Mahmoud",
                    "initial": "A.M.",
                    "last": "Mansour"
                },
                {
                    "first": "Nahed",
                    "initial": "N.",
                    "last": "Azazzy"
                },
                {
                    "first": "John P.",
                    "initial": "J.P.",
                    "last": "McCracken"
                },
                {
                    "first": "Joe P.",
                    "initial": "J.P.",
                    "last": "Bryan"
                },
                {
                    "first": "Maria R.",
                    "initial": "M.R.",
                    "last": "Lopez"
                },
                {
                    "first": "Deron C.",
                    "initial": "D.C.",
                    "last": "Burton"
                },
                {
                    "first": "Godfrey",
                    "initial": "G.",
                    "last": "Bigogo"
                },
                {
                    "first": "Robert F.",
                    "initial": "R.F.",
                    "last": "Breiman"
                },
                {
                    "first": "Daniel R.",
                    "initial": "D.R.",
                    "last": "Feikin"
                },
                {
                    "first": "Kariuki",
                    "initial": "K.",
                    "last": "Njenga"
                },
                {
                    "first": "Joel",
                    "initial": "J.",
                    "last": "Montgomery"
                },
                {
                    "first": "Adam L.",
                    "initial": "A.L.",
                    "last": "Cohen"
                },
                {
                    "first": "Jocelyn",
                    "initial": "J.",
                    "last": "Moyes"
                },
                {
                    "first": "Marthi",
                    "initial": "M.",
                    "last": "Pretorius"
                },
                {
                    "first": "Cheryl",
                    "initial": "C.",
                    "last": "Cohen"
                },
                {
                    "first": "Marietjie",
                    "initial": "M.",
                    "last": "Venter"
                },
                {
                    "first": "Malinee",
                    "initial": "M.",
                    "last": "Chittaganpitch"
                },
                {
                    "first": "Somsak",
                    "initial": "S.",
                    "last": "Thamthitiwat"
                },
                {
                    "first": "Pongpun",
                    "initial": "P.",
                    "last": "Sawatwong"
                },
                {
                    "first": "Henry C.",
                    "initial": "H.C.",
                    "last": "Baggett"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Luber"
                },
                {
                    "first": "Susan I.",
                    "initial": "S.I.",
                    "last": "Gerber"
                }
            ],
            "doi": "10.1093/infdis/jit515",
            "firstpage": "S246",
            "issn": "00221899",
            "lastpage": "S254",
            "pmid": "24265484",
            "pub_year": 2013,
            "title": "Respiratory syncytial virus circulation in seven countries with global disease detection regional centers",
            "volume": "208"
        },
        "b0040": null,
        "b0045": null,
        "b0050": null,
        "b0055": null,
        "b0060": {
            "authors": [
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Acedo"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "D\u00edez-Domingo"
                },
                {
                    "first": "J. A.",
                    "initial": "J.A.",
                    "last": "Mora\u00f1o"
                },
                {
                    "first": "R. J.",
                    "initial": "R.J.",
                    "last": "Villanueva"
                }
            ],
            "doi": "10.1017/S0950268809991373",
            "firstpage": "853",
            "issn": "09502688",
            "lastpage": "860",
            "pmid": "20003640",
            "pub_year": 2010,
            "title": "Mathematical modelling of respiratory syncytial virus (RSV): Vaccination strategies and budget applications",
            "volume": "138"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Deborah",
                    "initial": "D.",
                    "last": "Cromer"
                },
                {
                    "first": "Albert Jan",
                    "initial": "A.J.",
                    "last": "van Hoek"
                },
                {
                    "first": "Anthony T.",
                    "initial": "A.T.",
                    "last": "Newall"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Jit"
                }
            ],
            "doi": "10.1016/S2468-2667(17)30103-2",
            "firstpage": "e367",
            "issn": "24682667",
            "lastpage": "e374",
            "pub_year": 2017,
            "title": "Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England",
            "volume": "2"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Alexandra B.",
                    "initial": "A.B.",
                    "last": "Hogan"
                },
                {
                    "first": "Patricia T.",
                    "initial": "P.T.",
                    "last": "Campbell"
                },
                {
                    "first": "Christopher C.",
                    "initial": "C.C.",
                    "last": "Blyth"
                },
                {
                    "first": "Faye J.",
                    "initial": "F.J.",
                    "last": "Lim"
                },
                {
                    "first": "Parveen",
                    "initial": "P.",
                    "last": "Fathima"
                },
                {
                    "first": "Stephanie",
                    "initial": "S.",
                    "last": "Davis"
                },
                {
                    "first": "Hannah C.",
                    "initial": "H.C.",
                    "last": "Moore"
                },
                {
                    "first": "Kathryn",
                    "initial": "K.",
                    "last": "Glass"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.09.043",
            "firstpage": "6172",
            "issn": "0264410X",
            "lastpage": "6179",
            "pmid": "28967522",
            "pub_year": 2017,
            "title": "Potential impact of a maternal vaccine for RSV: A mathematical modelling study",
            "volume": "35"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Wirichada",
                    "initial": "W.",
                    "last": "Pan-Ngum"
                },
                {
                    "first": "Timothy",
                    "initial": "T.",
                    "last": "Kinyanjui"
                },
                {
                    "first": "Moses",
                    "initial": "M.",
                    "last": "Kiti"
                },
                {
                    "first": "Sylvia",
                    "initial": "S.",
                    "last": "Taylor"
                },
                {
                    "first": "Jean Fran\u00e7ois",
                    "initial": "J.F.",
                    "last": "Toussaint"
                },
                {
                    "first": "Sompob",
                    "initial": "S.",
                    "last": "Saralamba"
                },
                {
                    "first": "Thierry",
                    "initial": "T.",
                    "last": "Van Effelterre"
                },
                {
                    "first": "D. James",
                    "initial": "D.J.",
                    "last": "Nokes"
                },
                {
                    "first": "Lisa J.",
                    "initial": "L.J.",
                    "last": "White"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.10.073",
            "firstpage": "403",
            "issn": "0264410X",
            "lastpage": "409",
            "pmid": "27914740",
            "pub_year": 2017,
            "title": "Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach",
            "volume": "35"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Piero",
                    "initial": "P.",
                    "last": "Poletti"
                },
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Merler"
                },
                {
                    "first": "Marco",
                    "initial": "M.",
                    "last": "Ajelli"
                },
                {
                    "first": "Piero",
                    "initial": "P.",
                    "last": "Manfredi"
                },
                {
                    "first": "Patrick K.",
                    "initial": "P.K.",
                    "last": "Munywoki"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "James Nokes"
                },
                {
                    "first": "Alessia",
                    "initial": "A.",
                    "last": "Melegaro"
                }
            ],
            "doi": "10.1186/s12916-015-0283-x",
            "issn": "17417015",
            "pmid": "25857701",
            "pub_year": 2015,
            "title": "Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings",
            "volume": "13"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Stephane A.",
                    "initial": "S.A.",
                    "last": "R\u00e9gnier"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.07.024",
            "firstpage": "4347",
            "issn": "0264410X",
            "lastpage": "4354",
            "pmid": "23896421",
            "pub_year": 2013,
            "title": "Respiratory syncytial virus immunization program for the United States: Impact of performance determinants of a theoretical vaccine",
            "volume": "31"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Nienke M.",
                    "initial": "N.M.",
                    "last": "Scheltema"
                },
                {
                    "first": "Xynthia M.",
                    "initial": "X.M.",
                    "last": "Kavelaars"
                },
                {
                    "first": "Kentigern",
                    "initial": "K.",
                    "last": "Thorburn"
                },
                {
                    "first": "Marije P.",
                    "initial": "M.P.",
                    "last": "Hennus"
                },
                {
                    "first": "Job B.",
                    "initial": "J.B.",
                    "last": "van Woensel"
                },
                {
                    "first": "Cornelis K.",
                    "initial": "C.K.",
                    "last": "van der Ent"
                },
                {
                    "first": "Jos\u00e9 A.M.",
                    "initial": "J.A.M.",
                    "last": "Borghans"
                },
                {
                    "first": "Louis J.",
                    "initial": "L.J.",
                    "last": "Bont"
                },
                {
                    "first": "Julia",
                    "initial": "J.",
                    "last": "Drylewicz"
                }
            ],
            "doi": "10.1016/j.vaccine.2018.06.021",
            "firstpage": "4693",
            "issn": "0264410X",
            "lastpage": "4700",
            "pmid": "29941327",
            "pub_year": 2018,
            "title": "Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy",
            "volume": "36"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Dan",
                    "initial": "D.",
                    "last": "Yamin"
                },
                {
                    "first": "Forrest K.",
                    "initial": "F.K.",
                    "last": "Jones"
                },
                {
                    "first": "John P.",
                    "initial": "J.P.",
                    "last": "DeVincenzo"
                },
                {
                    "first": "Shai",
                    "initial": "S.",
                    "last": "Gertler"
                },
                {
                    "first": "Oren",
                    "initial": "O.",
                    "last": "Kobiler"
                },
                {
                    "first": "Jeffrey P.",
                    "initial": "J.P.",
                    "last": "Townsend"
                },
                {
                    "first": "Alison P.",
                    "initial": "A.P.",
                    "last": "Galvani"
                }
            ],
            "doi": "10.1073/pnas.1522597113",
            "firstpage": "13239",
            "issn": "00278424",
            "lastpage": "13244",
            "pmid": "27799521",
            "pub_year": 2016,
            "title": "Vaccination strategies against respiratory syncytial virus",
            "volume": "113"
        },
        "b0100": null,
        "b0105": {
            "authors": [
                {
                    "first": "W. Paul",
                    "initial": "W.P.",
                    "last": "Glezen"
                },
                {
                    "first": "Larry H.",
                    "initial": "L.H.",
                    "last": "Taber"
                },
                {
                    "first": "Arthur L.",
                    "initial": "A.L.",
                    "last": "Frank"
                },
                {
                    "first": "Julius A.",
                    "initial": "J.A.",
                    "last": "Kasel"
                }
            ],
            "doi": "10.1001/archpedi.1986.02140200053026",
            "firstpage": "543",
            "issn": "0002922X",
            "lastpage": "546",
            "pmid": "3706232",
            "pub_year": 1986,
            "title": "Risk of Primary Infection and Reinfection With Respiratory Syncytial Virus",
            "volume": "140"
        },
        "b0115": null,
        "b0130": null,
        "b0135": {
            "authors": [
                {
                    "first": "Holly A.",
                    "initial": "H.A.",
                    "last": "Hill"
                },
                {
                    "first": "Laurie D.",
                    "initial": "L.D.",
                    "last": "Elam-Evans"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Yankey"
                },
                {
                    "first": "James A.",
                    "initial": "J.A.",
                    "last": "Singleton"
                },
                {
                    "first": "Yoonjae",
                    "initial": "Y.",
                    "last": "Kang"
                }
            ],
            "doi": "10.15585/mmwr.mm6643a3",
            "firstpage": "1171",
            "issn": "01492195",
            "lastpage": "1177",
            "pmid": "29095807",
            "pub_year": 2017,
            "title": "Vaccination coverage among children aged 19\u201335 months \u2014 United States, 2016",
            "volume": "66"
        },
        "b0140": {
            "authors": [
                {
                    "first": "C. Mary",
                    "initial": "C.M.",
                    "last": "Healy"
                },
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Ng"
                },
                {
                    "first": "Ruston S.",
                    "initial": "R.S.",
                    "last": "Taylor"
                },
                {
                    "first": "Marcia A.",
                    "initial": "M.A.",
                    "last": "Rench"
                },
                {
                    "first": "Laurie S.",
                    "initial": "L.S.",
                    "last": "Swaim"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.07.018",
            "firstpage": "4983",
            "issn": "0264410X",
            "lastpage": "4987",
            "pmid": "26192356",
            "pub_year": 2015,
            "title": "Tetanus and diphtheria toxoids and acellular pertussis vaccine uptake during pregnancy in a metropolitan tertiary care center",
            "volume": "33"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Tea",
                    "initial": "T.",
                    "last": "Andabaka"
                },
                {
                    "first": "Jason W.",
                    "initial": "J.W.",
                    "last": "Nickerson"
                },
                {
                    "first": "Maria Ximena",
                    "initial": "M.X.",
                    "last": "Rojas-Reyes"
                },
                {
                    "first": "Juan David",
                    "initial": "J.D.",
                    "last": "Rueda"
                },
                {
                    "first": "Vesna",
                    "initial": "V.",
                    "last": "Bacic Vrca"
                },
                {
                    "first": "Bruno",
                    "initial": "B.",
                    "last": "Barsic"
                }
            ],
            "doi": "10.1002/14651858.CD006602.pub4",
            "issn": "1469493X",
            "pmid": "23633336",
            "pub_year": 2013,
            "title": "Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children",
            "volume": "2013"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                },
                {
                    "first": "Aruna",
                    "initial": "A.",
                    "last": "Chandran"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Weatherholtz"
                },
                {
                    "first": "Hasan S.",
                    "initial": "H.S.",
                    "last": "Jafri"
                },
                {
                    "first": "M. Pamela",
                    "initial": "M.P.",
                    "last": "Griffin"
                },
                {
                    "first": "Terramika",
                    "initial": "T.",
                    "last": "Bellamy"
                },
                {
                    "first": "Eugene V.",
                    "initial": "E.V.",
                    "last": "Millar"
                },
                {
                    "first": "Kathryn M.",
                    "initial": "K.M.",
                    "last": "Jensen"
                },
                {
                    "first": "Brian S.",
                    "initial": "B.S.",
                    "last": "Harris"
                },
                {
                    "first": "Raymond",
                    "initial": "R.",
                    "last": "Reid"
                },
                {
                    "first": "Lawrence H.",
                    "initial": "L.H.",
                    "last": "Moulton"
                },
                {
                    "first": "Genevieve A.",
                    "initial": "G.A.",
                    "last": "Losonsky"
                },
                {
                    "first": "Ruth A.",
                    "initial": "R.A.",
                    "last": "Karron"
                },
                {
                    "first": "Mathuram",
                    "initial": "M.",
                    "last": "Santosham"
                },
                {
                    "first": "Connie",
                    "initial": "C.",
                    "last": "Donaldson"
                },
                {
                    "first": "Angie",
                    "initial": "A.",
                    "last": "Eick-Cost"
                },
                {
                    "first": "Mindy",
                    "initial": "M.",
                    "last": "Perilla"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Campbell"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "VanDeReit"
                },
                {
                    "first": "Laura B.",
                    "initial": "L.B.",
                    "last": "Brown"
                },
                {
                    "first": "P. William",
                    "initial": "P.W.",
                    "last": "Gloyd"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Seby"
                },
                {
                    "first": "Mark A.",
                    "initial": "M.A.",
                    "last": "Brown"
                },
                {
                    "first": "Delfno",
                    "initial": "D.",
                    "last": "Candelaria"
                },
                {
                    "first": "Jeffrey L.",
                    "initial": "J.L.",
                    "last": "Foti"
                },
                {
                    "first": "Gary",
                    "initial": "G.",
                    "last": "Overturf"
                }
            ],
            "doi": "10.1016/S1473-3099(15)00247-9",
            "firstpage": "1398",
            "issn": "14733099",
            "lastpage": "1408",
            "pmid": "26511956",
            "pub_year": 2015,
            "title": "Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: A phase 3 randomised double-blind placebo-controlled trial",
            "volume": "15"
        }
    },
    "body_text": [
        {
            "endOffset": 23603,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0035",
            "sentence": "Since data are sparse on the number of RSV-associated deaths that occur outside the hospital setting, we estimated deaths with and without immunization based on deaths among hospitalized infants.",
            "startOffset": 23408,
            "title": "Deaths with and without immunization"
        },
        {
            "endOffset": 37844,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Discussion"
                }
            ],
            "secId": "s0075",
            "sentence": "Although we found limited impact of these products on deaths averted in the United States, they may have greater impact in places where RSV-associated deaths are more common.",
            "startOffset": 37670,
            "title": "Conclusions"
        },
        {
            "endOffset": 20226,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Users can readily update a number of input values as new data become available or to reflect a jurisdiction\u2019s immunization policy considerations.",
            "startOffset": 20081,
            "title": "Tool overview"
        },
        {
            "endOffset": 24119,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0035",
            "sentence": "Deaths prevented by immunization were calculated similarly to medically-attended visits prevented, whereby deaths that occur without immunization were multiplied by the uptake and efficacy for each product.",
            "startOffset": 23913,
            "title": "Deaths with and without immunization"
        },
        {
            "endOffset": 37410,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Discussion"
                }
            ],
            "secId": "s0075",
            "sentence": "As such, local and national public health agencies may use it to evaluate jurisdiction-specific scenarios of impact.",
            "startOffset": 37294,
            "title": "Conclusions"
        },
        {
            "endOffset": 24284,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0035",
            "sentence": "Finally, deaths that would occur despite having each immunization strategy in place equaled deaths without immunization minus deaths prevented through immunization.",
            "startOffset": 24120,
            "title": "Deaths with and without immunization"
        },
        {
            "endOffset": 27154,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Strategy III (the \u201cMaternal Vaccine Candidate + Palivizumab\u201d), prevented an estimated 58,210 (14% of visits without immunization) RSV-associated LRTIs attended in the outpatient clinic setting (range: 48,520\u201367,970), 19,580 (13%) LRTIs attended in the ED (range: 16,760\u201322,400), and 8190 (25%) LRTI hospitalizations (range: 6,390\u201310,150).",
            "startOffset": 26816,
            "title": "Visits prevented with immunization"
        },
        {
            "endOffset": 35782,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 35781,
                    "startOffset": 35777
                }
            },
            "secId": "s0070",
            "sentence": "It is possible that these products will shift the demand for care to subsequent seasons, although there is evidence that primary infection with RSV beyond 12 months of age is less likely to result in an LRTI [21].",
            "startOffset": 35569,
            "title": "Discussion"
        },
        {
            "endOffset": 21664,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0025",
            "sentence": "For the outpatient clinic and ED settings, we assumed the ratio of rates between high- and low-risk infants is the same as the ratio of hospitalization rates for high and low risk infants, and that palivizumab would have the same efficacy for preventing cases in these settings (S2).",
            "startOffset": 21381,
            "title": "Visits without immunization"
        },
        {
            "endOffset": 26815,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "(Fig. 1) This strategy prevents an estimated 196,470 (48% of visits without immunization) RSV-associated LRTIs attended in the outpatient clinic setting (range: 163,810\u2013229,650), 75,250 (51%) LRTIs attended in the ED (range: 64,430\u201386,090), and 18,140 (55%) LRTI hospitalizations (range: 13,770\u201323,160).",
            "startOffset": 26512,
            "title": "Visits prevented with immunization"
        },
        {
            "endOffset": 14298,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 14297,
                    "startOffset": 14292
                },
                "b0025": {
                    "endOffset": 14297,
                    "startOffset": 14292
                }
            },
            "secId": "s0005",
            "sentence": "Rates of medically-attended RSVi (MA-RSVi) in the United States are highest amongst infants < 6 months of age [4,5].",
            "startOffset": 14182,
            "title": "Introduction"
        },
        {
            "endOffset": 24444,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "To illustrate the model, we estimated the impact of implementing the three immunization strategies in the United States.",
            "startOffset": 24324,
            "title": "Model inputs and sensitivity analysis"
        },
        {
            "endOffset": 34645,
            "parents": [],
            "secId": "s0070",
            "sentence": "A strength of our study is its simplicity.",
            "startOffset": 34603,
            "title": "Discussion"
        },
        {
            "endOffset": 36099,
            "parents": [],
            "secId": "s0070",
            "sentence": "Other limitations, however, may result in our overestimation of immunization benefits.",
            "startOffset": 36013,
            "title": "Discussion"
        },
        {
            "endOffset": 31935,
            "parents": [],
            "secId": "s0070",
            "sentence": "Consequently, changes to our duration assumptions for the maternal vaccine candidate had the greatest influence on product impact.",
            "startOffset": 31805,
            "title": "Discussion"
        },
        {
            "endOffset": 26511,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "In our illustrative scenario, Strategy II (the \u201cAntibody Candidate\u201d) prevented the most annual LRTIs.",
            "startOffset": 26410,
            "title": "Visits prevented with immunization"
        },
        {
            "endOffset": 16869,
            "parents": [],
            "secId": "s0005",
            "sentence": "We therefore developed a modeling tool, called the RSV Immunization Impact Model (RSV I2M), for use by practicing public health officials and policy-makers in their jurisdictions, to estimate the direct effects of immunization candidates targeting young infants, on MA-RSV-associated LRTIs.",
            "startOffset": 16579,
            "title": "Introduction"
        },
        {
            "endOffset": 36915,
            "parents": [],
            "secId": "s0070",
            "sentence": "For jurisdictions that do not use palivizumab or who wish to see the potential impact of the maternal vaccine alone, users can set palivizumab uptake to 0%.",
            "startOffset": 36759,
            "title": "Discussion"
        },
        {
            "endOffset": 29041,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The more pronounced effects of immunization duration in Strategy III results from RSV rates peaking for the outpatient and ED setting at ages just after our baseline 90-day duration (Table S1).",
            "startOffset": 28848,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 27750,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "We estimated 33 deaths (range: 25\u201343) would occur annually among hospitalized infants in the US from RSV-associated LRTIs in the absence of immunization, and following current recommendations for palivizumab use (Strategy I) prevents just one death.",
            "startOffset": 27501,
            "title": "Deaths with and without immunization"
        },
        {
            "endOffset": 30354,
            "parents": [],
            "secId": "s0070",
            "sentence": "Using the model and our best estimates of the parameters, we found that in the absence of an immunization, there are \u223c590,000 MA-RSV LRTIs among US infants and that new interventions that target all infants may prevent between \u223c86,000 to \u223c290,000 of those visits.",
            "startOffset": 30091,
            "title": "Discussion"
        },
        {
            "endOffset": 32286,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 32285,
                    "startOffset": 32281
                }
            },
            "secId": "s0070",
            "sentence": "Preliminary results suggest the efficacy of a maternal vaccine may be half what we assumed in our baseline estimates [20].",
            "startOffset": 32164,
            "title": "Discussion"
        },
        {
            "endOffset": 23367,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0030",
            "sentence": "Finally, we calculated the visits that would occur despite having each immunization strategy in place: this equaled visits without immunization minus visits prevented.",
            "startOffset": 23200,
            "title": "Visits prevented with immunization"
        },
        {
            "endOffset": 16148,
            "parents": [],
            "secId": "s0005",
            "sentence": "While Cromer et al.\u2019s model more closely matches trial endpoints for products potentially close to licensure, its assumptions may not be generalizable to populations that have different rates of disease and seasonality.",
            "startOffset": 15929,
            "title": "Introduction"
        },
        {
            "endOffset": 33816,
            "parents": [],
            "secId": "s0070",
            "sentence": "If we assume 100% uptake for both candidate products and limit our evaluation to infants <6 months of age (to match Cromer et al.\u2019s analysis) we find the antibody candidate prevents 1.7 times more hospitalizations than the maternal vaccine candidate, compared with a ratio of 1.8 in Cromer et al.",
            "startOffset": 33520,
            "title": "Discussion"
        },
        {
            "endOffset": 15508,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 15507,
                    "startOffset": 15500
                },
                "b0065": {
                    "endOffset": 15507,
                    "startOffset": 15500
                },
                "b0070": {
                    "endOffset": 15507,
                    "startOffset": 15500
                },
                "b0075": {
                    "endOffset": 15507,
                    "startOffset": 15500
                },
                "b0080": {
                    "endOffset": 15507,
                    "startOffset": 15500
                },
                "b0085": {
                    "endOffset": 15507,
                    "startOffset": 15500
                },
                "b0090": {
                    "endOffset": 15507,
                    "startOffset": 15500
                },
                "b0095": {
                    "endOffset": 15507,
                    "startOffset": 15500
                }
            },
            "secId": "s0005",
            "sentence": "Previous studies have evaluated the potential impacts of immunization on MA-RSVi in a variety of countries [12\u201319].",
            "startOffset": 15393,
            "title": "Introduction"
        },
        {
            "endOffset": 29432,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The results of our multivariable sensitivity analysis suggest changes in the antibody candidate uptake have a larger impact in preventing RSV-associated LRTI visits than would uptake changes in the maternal vaccine candidate.",
            "startOffset": 29207,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 17731,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "RSV I2M is a spreadsheet-based tool (Supplementary Material [S1]) that uses a Decision Tree model to estimate the potential impact of three immunization strategies on MA-RSV-associated LRTIs among an annual birth cohort through 12 months of age.",
            "startOffset": 17486,
            "title": "Tool overview"
        },
        {
            "endOffset": 31045,
            "parents": [],
            "secId": "s0070",
            "sentence": "With this strategy, we estimate nearly 200,000 outpatient clinic visits, 75,000 ED visits, and 18,000 hospitalizations for LRTIs could be prevented annually; approximately 48\u201355% (across settings) of visits estimated to occur without immunization.",
            "startOffset": 30798,
            "title": "Discussion"
        },
        {
            "endOffset": 29881,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "In the ED setting, a one percentage point increase in antibody candidate uptake is associated with 548\u20131,248 LRTI visits prevented, while the same uptake increase in maternal vaccine candidate would prevent between 82 and 588 LRTIs.",
            "startOffset": 29649,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 37099,
            "parents": [],
            "secId": "s0070",
            "sentence": "It is worth noting that similar flexibility exists for analyzing impacts by setting: jurisdictions wishing to evaluate only the hospital setting can just input rates for this setting.",
            "startOffset": 36916,
            "title": "Discussion"
        },
        {
            "endOffset": 23912,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0035",
            "sentence": "We calculated deaths without immunization by multiplying user-provided hospitalized case fatality ratios (hCFR) for infants 0\u20135 months of age and for those between 6 and 11 months of age and the total annual estimate for hospitalizations due to RSV-associated LRTIs without immunization for these age groups.",
            "startOffset": 23604,
            "title": "Deaths with and without immunization"
        },
        {
            "endOffset": 26373,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "We estimate, in the absence of palivizumab use, RSV-associated LRTIs in the US among infants up to 12 months of age, would result in 407,360 annual outpatient clinic visits (range, based on RSV rates uncertainty: 339,650\u2013475,980); 147,240 annual ED visits (range: 126,070\u2013168,510), and annual 33,180 hospitalizations (range: 24,760\u201342,900).",
            "startOffset": 26033,
            "title": "Visits without immunization"
        },
        {
            "endOffset": 35457,
            "parents": [],
            "secId": "s0070",
            "sentence": "Additional strengths of our study include evaluation of multiple candidate products, the separate consideration of infants with higher risk of healthcare use for RSV infection and the additional evaluation of the outpatient and emergency department settings.",
            "startOffset": 35199,
            "title": "Discussion"
        },
        {
            "endOffset": 36637,
            "parents": [],
            "secId": "s0070",
            "sentence": "We also assumed an additive effect of palivizumab on top of visits prevented by the maternal vaccine candidate in Strategy III, on the basis that the population of \u201chigh-risk\u201d births may derive partial protection from the maternal vaccine and from palivizumab.",
            "startOffset": 36377,
            "title": "Discussion"
        },
        {
            "endOffset": 25995,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "High estimates were achieved by combining the 97.5 percentile values for MA-RSVi rates, highest efficacy and uptake, and longest duration, for each product.",
            "startOffset": 25839,
            "title": "Model inputs and sensitivity analysis"
        },
        {
            "endOffset": 13634,
            "parents": [],
            "secId": "s0005",
            "sentence": "Globally, respiratory syncytial virus (RSV) is a leading cause of severe respiratory tract infections among young children.",
            "startOffset": 13511,
            "title": "Introduction"
        },
        {
            "endOffset": 18750,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The second strategy (Strategy II) provides a new antibody product, hereafter referred to as the \u201cAntibody Candidate\u201d strategy, injected as a single dose with the same timing of palivizumab initiation, but targeting all infants rather than just those at high risk.",
            "startOffset": 18487,
            "title": "Tool overview"
        },
        {
            "endOffset": 29207,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "In contrast, efficacy was the least influential parameter in Strategy III.",
            "startOffset": 29133,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 25279,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "For this analysis we used the 95% CI bounds for MA-RSVi rates, five percentage point reductions and improvements in the baseline uptake for the antibody candidate (66\u201376%) and maternal vaccine candidate (51\u201361%), the 95% CI bounds for efficacy reported in clinical trial results for an antibody candidate (73\u201385%, which we assumed for the maternal vaccine candidate as well), and one month reductions and improvements in durations of the antibody candidate (120\u2013180 days), and maternal vaccine candidate (60\u2013120 days) (Table 2).",
            "startOffset": 24751,
            "title": "Model inputs and sensitivity analysis"
        },
        {
            "endOffset": 29132,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Antibody candidate uptake exhibited the least influence on prevented LRTIs in Strategy II.",
            "startOffset": 29042,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 19041,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The third strategy (Strategy III), the \u201cMaternal Vaccine Candidate + Palivizumab\u201d strategy, combines providing vaccine to mothers in their third trimester throughout the year (not just during the season) and palivizumab to high-risk births based on the palivizumab schedule described above.",
            "startOffset": 18751,
            "title": "Tool overview"
        },
        {
            "endOffset": 17462,
            "parents": [],
            "secId": "s0005",
            "sentence": "We also apply the model to a US birth cohort to estimate the potential impact of these products on MA-LRTI due to RSV in the United States.",
            "startOffset": 17323,
            "title": "Introduction"
        },
        {
            "endOffset": 33096,
            "parents": [],
            "secId": "s0070",
            "sentence": "Similarly, a 10% increase in maternal vaccine candidate uptake is associated with preventing 2,730\u201316,110 outpatient clinic visits, 820\u20135,880 ED visits, and 580\u20132,150 hospitalizations for LRTIs.",
            "startOffset": 32902,
            "title": "Discussion"
        },
        {
            "endOffset": 25658,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "We present the results for this analysis as the lowest and highest possible prevented visits associated with a percentage point decrease or increase in uptake, respectively.",
            "startOffset": 25485,
            "title": "Model inputs and sensitivity analysis"
        },
        {
            "endOffset": 32163,
            "parents": [],
            "secId": "s0070",
            "sentence": "Despite its lower impact, the maternal vaccine candidate has the potential to reduce MA-RSV LRTIs across all three settings by \u223c74,000 visits a year (beyond the \u223c12,500 visits prevented by palivizumab in our baseline scenario).",
            "startOffset": 31936,
            "title": "Discussion"
        },
        {
            "endOffset": 14746,
            "parents": [],
            "secId": "s0005",
            "sentence": "It is given in monthly intramuscular injections during RSV season.",
            "startOffset": 14680,
            "title": "Introduction"
        },
        {
            "endOffset": 27943,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Eighteen in-hospital deaths (range: 14\u201323) would be prevented if immunization were implemented according to Strategy II, and eight in-hospital deaths (range: 6\u201310) prevented with Strategy III.",
            "startOffset": 27751,
            "title": "Deaths with and without immunization"
        },
        {
            "endOffset": 13965,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 13964,
                    "startOffset": 13961
                }
            },
            "secId": "s0005",
            "sentence": "About 45% of RSV-associated hospitalizations and deaths occurred among children <6 months of age [1].",
            "startOffset": 13864,
            "title": "Introduction"
        },
        {
            "endOffset": 30797,
            "parents": [],
            "secId": "s0070",
            "sentence": "Of the candidates evaluated, administering an antibody candidate to all infants born during the season and at the season\u2019s start for those born outside the season, prevents the most MA-LRTIs.",
            "startOffset": 30606,
            "title": "Discussion"
        },
        {
            "endOffset": 19692,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Uptake was defined as the proportion of the population expected to receive the products.",
            "startOffset": 19604,
            "title": "Tool overview"
        },
        {
            "endOffset": 34812,
            "parents": [],
            "secId": "s0070",
            "sentence": "We focus on the impacts of products on infants who are actually immunized, which will be of specific interest to policy-makers developing RSV immunization guidelines.",
            "startOffset": 34646,
            "title": "Discussion"
        },
        {
            "endOffset": 22561,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0030",
            "sentence": "The efficacies for both candidates assumes recipients receive the full immunization dose.",
            "startOffset": 22472,
            "title": "Visits prevented with immunization"
        },
        {
            "endOffset": 34602,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 34601,
                    "startOffset": 34597
                }
            },
            "secId": "s0070",
            "sentence": "And Hogan et al., employing a compartmental transmission model to examine maternal vaccine impacts in Western Australia, similarly estimated a 25% reduction in hospitalizations when assuming a similar immunization scenario of 50% uptake, 80% efficacy, and 3 months duration of protection [14].",
            "startOffset": 34309,
            "title": "Discussion"
        },
        {
            "endOffset": 36012,
            "parents": [],
            "secId": "s0070",
            "sentence": "As such, and because we do not account for herd effects, we may underestimate the actual benefit of immunizing mothers.",
            "startOffset": 35893,
            "title": "Discussion"
        },
        {
            "endOffset": 34968,
            "parents": [],
            "secId": "s0070",
            "sentence": "However, this should not be seen as a limitation.",
            "startOffset": 34919,
            "title": "Discussion"
        },
        {
            "endOffset": 14837,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 14836,
                    "startOffset": 14833
                }
            },
            "secId": "s0005",
            "sentence": "There are over 40 vaccine and antibody products in development for prevention of RSVi [9].",
            "startOffset": 14747,
            "title": "Introduction"
        },
        {
            "endOffset": 21931,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0030",
            "sentence": "To obtain the annual number of visits prevented with immunization for a given strategy and setting, we summed the visits prevented across all months that the immunization remained protective, based on its duration of protection.",
            "startOffset": 21703,
            "title": "Visits prevented with immunization"
        },
        {
            "endOffset": 14679,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 14678,
                    "startOffset": 14675
                }
            },
            "secId": "s0005",
            "sentence": "Palivizumab, currently the only licensed product to prevent RSVi, is recommended for use in children with certain \u201chigh risk\u201d conditions [8].",
            "startOffset": 14538,
            "title": "Introduction"
        },
        {
            "endOffset": 20873,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0025",
            "sentence": "These results were then distributed to calendar months based on RSV seasonality by multiplying them by the percent of annual visits occurring in each month.",
            "startOffset": 20717,
            "title": "Visits without immunization"
        },
        {
            "endOffset": 22986,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0030",
            "sentence": "This factor considers the delay in the mother\u2019s production of antibodies after vaccination (dependent on the timing of vaccination relative to birth) and the fact that the amount of antibody transfer is dependent on gestational age at birth (S2).",
            "startOffset": 22740,
            "title": "Visits prevented with immunization"
        },
        {
            "endOffset": 32631,
            "parents": [],
            "secId": "s0070",
            "sentence": "Although uncertainty in factors over which public health practitioners have some influence, like uptake, had less impact on results, they were not trivial.",
            "startOffset": 32476,
            "title": "Discussion"
        },
        {
            "endOffset": 17812,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The birth cohort is divided into \u201chigh-risk\u201d and \u201clow-risk\u201d (all other) infants.",
            "startOffset": 17732,
            "title": "Tool overview"
        },
        {
            "endOffset": 16303,
            "parents": [],
            "secId": "s0005",
            "sentence": "It also assumed the entire population eligible for an immunization product received it (i.e. 100% uptake), which likely overestimates the public response.",
            "startOffset": 16149,
            "title": "Introduction"
        },
        {
            "endOffset": 32901,
            "parents": [],
            "secId": "s0070",
            "sentence": "For example, our multivariable sensitivity analysis suggests a 10% increase in uptake of the antibody candidate is associated with preventing an additional 14,350 to 35,270 outpatient clinic visits, 5,480\u201312,480 ED visits, and 1,280 to 3,290 hospitalizations for LRTIs.",
            "startOffset": 32632,
            "title": "Discussion"
        },
        {
            "endOffset": 16579,
            "parents": [],
            "secId": "s0005",
            "sentence": "The evolving state of product development highlights the need for flexible and accessible modeling tools, which can be readily updated to reflect advancements in our knowledge of product characteristics, and which can be applied to jurisdictions with varied RSV epidemiology.",
            "startOffset": 16304,
            "title": "Introduction"
        },
        {
            "endOffset": 38051,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Discussion"
                }
            ],
            "secId": "s0075",
            "sentence": "As more data become available regarding immunization candidates (i.e. study results regarding efficacy and length of protection) and the burden of RSV infections, our tool permits rapid updating of results.",
            "startOffset": 37845,
            "title": "Conclusions"
        },
        {
            "endOffset": 38374,
            "parents": [],
            "secId": "ce.section_ttb_mrh_qjb",
            "sentence": "This research did not receive any specific grant from funding agencies in the public, commercial, or not-for profit sectors.",
            "startOffset": 38250,
            "title": "Declaration of interests:"
        },
        {
            "endOffset": 15771,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 15770,
                    "startOffset": 15766
                }
            },
            "secId": "s0005",
            "sentence": "Only one (Cromer et al.) simultaneously compared multiple products in the later stages of clinical development and across several healthcare settings [13].",
            "startOffset": 15616,
            "title": "Introduction"
        },
        {
            "endOffset": 22739,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0030",
            "sentence": "To account for incomplete transfer of antibodies from mother to child for a portion of births, we multiplied the maternal vaccine efficacy in Strategy III by a reduction factor.",
            "startOffset": 22562,
            "title": "Visits prevented with immunization"
        },
        {
            "endOffset": 22471,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0030",
            "sentence": "For Strategies II and III, visits prevented by the immunization candidates equaled the number of MA-RSV-associated LRTIs without immunization among both high- and low-risk infants, multiplied by the candidate uptake in each risk group and efficacy.",
            "startOffset": 22223,
            "title": "Visits prevented with immunization"
        },
        {
            "endOffset": 20716,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0025",
            "sentence": "To calculate the number of MA-RSVi resulting in LRTI for each of the three healthcare settings, we multiplied the \u201call-risk\u201d (high- and low-risk) MA-RSVi rate by the proportion of visits in each setting with an LRTI diagnosis and the size of monthly birth cohorts (assuming births occur evenly across the year) (S2).",
            "startOffset": 20400,
            "title": "Visits without immunization"
        },
        {
            "endOffset": 15296,
            "parents": [],
            "secId": "s0005",
            "sentence": "Both of these products aim to protect against medically-attended lower respiratory tract infections (MA-LRTI) due to RSV.",
            "startOffset": 15175,
            "title": "Introduction"
        },
        {
            "endOffset": 21262,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0025",
            "sentence": "For the hospital setting, these additional visits were determined by multiplying the rate of hospitalizations among high-risk infants by the size of the high-risk cohort, palivizumab uptake, and palivizumab efficacy.",
            "startOffset": 21046,
            "title": "Visits without immunization"
        },
        {
            "endOffset": 24535,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Table 2 includes all model inputs, values used and sources (with additional detail in S2).",
            "startOffset": 24445,
            "title": "Model inputs and sensitivity analysis"
        },
        {
            "endOffset": 24609,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "We conducted two sensitivity analyses of immunization candidates\u2019 impacts.",
            "startOffset": 24535,
            "title": "Model inputs and sensitivity analysis"
        },
        {
            "endOffset": 24750,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "In the first, we evaluated the influence of high and low estimates for individual parameters, while all other parameters were held constant.",
            "startOffset": 24610,
            "title": "Model inputs and sensitivity analysis"
        },
        {
            "endOffset": 20353,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "To illustrate the tool, we used it to estimate the effects of the aforementioned immunization strategies on a US birth cohort.",
            "startOffset": 20227,
            "title": "Tool overview"
        },
        {
            "endOffset": 21045,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0025",
            "sentence": "For countries that currently use palivizumab, like the United States, we added to the monthly visit counts MA-LRTIs that would have occurred in the absence of palivizumab.",
            "startOffset": 20874,
            "title": "Visits without immunization"
        },
        {
            "endOffset": 15174,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 15016,
                    "startOffset": 15012
                },
                "b0055": {
                    "endOffset": 15173,
                    "startOffset": 15169
                }
            },
            "secId": "s0005",
            "sentence": "Two products in late stages of clinical development target young infants: (1) a monoclonal antibody designed to provide direct protection (completed phase 2b clinical trial) [10]; and (2) a maternal vaccine designed to provide indirect protection through passive placental transfer of antibodies (completed phase 3 clinical trial) [11].",
            "startOffset": 14838,
            "title": "Introduction"
        },
        {
            "endOffset": 21380,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0025",
            "sentence": "The hospitalization rates used in this calculation are a weighted average across the different high-risk groups (S2).",
            "startOffset": 21263,
            "title": "Visits without immunization"
        },
        {
            "endOffset": 25484,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "In our second sensitivity analysis, we examined the impact of uptake of the immunization candidates on LRTI visits by accounting simultaneously for uncertainty in RSV rates, uptake, efficacy, and duration.",
            "startOffset": 25279,
            "title": "Model inputs and sensitivity analysis"
        },
        {
            "endOffset": 32476,
            "parents": [],
            "secId": "s0070",
            "sentence": "This would reduce visits prevented by the maternal vaccine candidate by about half, but not change the overall conclusion about the relative merits of the products and strategies evaluated.",
            "startOffset": 32287,
            "title": "Discussion"
        },
        {
            "endOffset": 28847,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "When results assuming 60 and 120 days of protection by the maternal vaccine candidate are compared, the estimated LRTI visits prevented differed by 3,880 in the hospital setting, 20,950 in the ED setting, and 51,840 in the outpatient clinic setting.",
            "startOffset": 28598,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 33519,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 33518,
                    "startOffset": 33514
                }
            },
            "secId": "s0070",
            "sentence": "The relative impact of strategies on hospitalizations are similar to Cromer et al.\u2019s findings (ED and outpatients are not comparable) [13].",
            "startOffset": 33380,
            "title": "Discussion"
        },
        {
            "endOffset": 13863,
            "parents": [],
            "secId": "s0005",
            "sentence": "In 2015, there were an estimated 33.1 million acute lower respiratory tract infections, 3.2 million hospital admissions and 59,600 in-hospital deaths attributed to RSV infections (RSVi) among children < 5 years of age worldwide.",
            "startOffset": 13635,
            "title": "Introduction"
        },
        {
            "endOffset": 15393,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 15392,
                    "startOffset": 15389
                }
            },
            "secId": "s0005",
            "sentence": "Additional maternal vaccines and antibody products are in the clinical development pipeline [9].",
            "startOffset": 15297,
            "title": "Introduction"
        },
        {
            "endOffset": 14538,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 14537,
                    "startOffset": 14534
                }
            },
            "secId": "s0005",
            "sentence": "In countries with tropical or subtropical climates, the season may be longer and less predictable [7].",
            "startOffset": 14436,
            "title": "Introduction"
        },
        {
            "endOffset": 23199,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0030",
            "sentence": "In Strategy III, high-risk infants are also eligible to receive palivizumab; therefore, we added the number of visits prevented by palivizumab when calculating the total annual prevented visits for this strategy.",
            "startOffset": 22987,
            "title": "Visits prevented with immunization"
        },
        {
            "endOffset": 31385,
            "parents": [],
            "secId": "s0070",
            "sentence": "Our baseline estimates suggest this strategy may avert approximately 3.5 times the number visits for RSV-associated LRTIs to outpatient clinics and EDs, and two times the hospitalizations than a strategy in which a maternal vaccine candidate is offered to mothers year-round (in addition to palivizumab use per current US recommendations).",
            "startOffset": 31046,
            "title": "Discussion"
        },
        {
            "endOffset": 19464,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Estimates of MA-RSVi visits without any immunization are based upon user inputs regarding the size of their birth cohort, prevalence and risk of RSV hospitalizations among those with high-risk conditions, rates of RSV (combined for high- and low-risk infants) by month of age in the outpatient clinic, ED, and hospital settings, the proportion of MA-RSVi visits resulting in a LRTI diagnosis, and RSV seasonality (Table 2).",
            "startOffset": 19041,
            "title": "Tool overview"
        },
        {
            "endOffset": 30605,
            "parents": [],
            "secId": "s0070",
            "sentence": "Few deaths (8\u201318), however, are averted, since few deaths in the US are attributed to RSVi.",
            "startOffset": 30514,
            "title": "Discussion"
        },
        {
            "endOffset": 22019,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0030",
            "sentence": "We calculated the monthly visits prevented with each immunization strategy differently.",
            "startOffset": 21932,
            "title": "Visits prevented with immunization"
        },
        {
            "endOffset": 28354,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "In both Strategies II and III, uncertainty in the duration of immunization protection was the most influential parameter, except for the hospital setting, where uncertainty in RSV rates was more influential in Strategy II (Fig. 2).",
            "startOffset": 28123,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 27462,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "We estimate that Strategy I, (\u201cCurrent US Recommendations\u201d), prevents 8,460 (2% of visits without immunization) RSV-associated LRTIs attended in the outpatient clinic setting (range: 7,050\u20139,880), 3,240 (2%) LRTIs attended in the ED (range: 2,770\u20133,710), and 780 (2%) LRTI hospitalizations (range: 760\u2013800).",
            "startOffset": 27155,
            "title": "Visits prevented with immunization"
        },
        {
            "endOffset": 36376,
            "parents": [],
            "secId": "s0070",
            "sentence": "For example, our assumption that effective immunization averts healthcare use does not account for the potential that some portion of immunized infants may still become infected with RSV, but require a lower level of care (e.g. shift from hospitalization to outpatient visit).",
            "startOffset": 36100,
            "title": "Discussion"
        },
        {
            "endOffset": 18297,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0040": {
                    "endOffset": 18297,
                    "startOffset": 18294
                }
            },
            "secId": "s0015",
            "sentence": "The first strategy (Strategy I) generally follows current US-based recommendations that high-risk infants receive monthly injections of palivizumab during the RSV season (typically October to March) during their first year of life. [8]",
            "startOffset": 18062,
            "title": "Tool overview"
        },
        {
            "endOffset": 37669,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Discussion"
                }
            ],
            "secId": "s0075",
            "sentence": "The results of our illustrative scenario underscore potential for these products to reduce serious RSV illness and the benefits of each.",
            "startOffset": 37533,
            "title": "Conclusions"
        },
        {
            "endOffset": 15928,
            "parents": [],
            "secId": "s0005",
            "sentence": "Cromer et al. estimated the direct effects of various pediatric and maternal immunization candidate products and strategies using a cohort model in England.",
            "startOffset": 15772,
            "title": "Introduction"
        },
        {
            "endOffset": 29648,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "For every percentage point increase in uptake of the antibody candidate, we estimate 1,435\u20133,527 outpatient visits would be prevented, compared with 273\u20131,611 for the same increase in the maternal vaccine candidate.",
            "startOffset": 29433,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 35481,
            "parents": [],
            "secId": "s0070",
            "sentence": "RSV I2M has limitations.",
            "startOffset": 35457,
            "title": "Discussion"
        },
        {
            "endOffset": 31631,
            "parents": [],
            "secId": "s0070",
            "sentence": "In our illustrative scenario, the difference in the number of prevented visits associated with candidates was largely attributable to the maternal candidate\u2019s duration of protection being less than the antibody candidates\u2019 duration of protection.",
            "startOffset": 31385,
            "title": "Discussion"
        },
        {
            "endOffset": 14181,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 14180,
                    "startOffset": 14175
                },
                "b0015": {
                    "endOffset": 14180,
                    "startOffset": 14175
                }
            },
            "secId": "s0005",
            "sentence": "Each year in the United States, \u223c1.5 million outpatient visits, \u223c500,000 emergency department (ED) visits, \u223c58,000 hospitalizations and \u223c150 deaths are associated with RSVi among children under 5 years of age [2,3].",
            "startOffset": 13966,
            "title": "Introduction"
        },
        {
            "endOffset": 22222,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0020",
                    "title": "Calculations"
                }
            ],
            "secId": "s0030",
            "sentence": "For Strategy I, LRTI visits prevented by palivizumab equaled the calculated number of MA-RSV-associated LRTIs without immunization among high-risk infants, multiplied by palivizumab uptake and efficacy.",
            "startOffset": 22020,
            "title": "Visits prevented with immunization"
        },
        {
            "endOffset": 14435,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 14434,
                    "startOffset": 14431
                }
            },
            "secId": "s0005",
            "sentence": "In the US and other temperate climates, RSV season generally lasts six months between fall and spring with a peak during the winter [6].",
            "startOffset": 14299,
            "title": "Introduction"
        },
        {
            "endOffset": 18061,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0040": {
                    "endOffset": 18060,
                    "startOffset": 18057
                }
            },
            "secId": "s0015",
            "sentence": "High-risk infants include those with hemodynamically significant CHD, chronic lung disease of prematurity (CLDP), and infants born prematurely at <29 weeks gestational age based on recommendations for who should receive palivizumab prophylaxis [8].",
            "startOffset": 17813,
            "title": "Tool overview"
        },
        {
            "endOffset": 19813,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Efficacy is defined as the percent protected assuming recipients receive the full immunization dose at the correct time.",
            "startOffset": 19693,
            "title": "Tool overview"
        },
        {
            "endOffset": 19603,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "To estimate the effects of immunization, users input immunization uptake, efficacy, and duration of protection for each product (Table 2).",
            "startOffset": 19465,
            "title": "Tool overview"
        },
        {
            "endOffset": 20080,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "For the maternal vaccine, efficacy is reduced by assumptions about the proportion of antibodies that successfully transfer to the infant (based on the timing of the mother\u2019s vaccination and the infant\u2019s gestational age a birth; Table 2, Supplementary Material [S2]).",
            "startOffset": 19814,
            "title": "Tool overview"
        },
        {
            "endOffset": 34918,
            "parents": [],
            "secId": "s0070",
            "sentence": "We do not estimate the indirect effects of immunization in infants (i.e. secondary infections prevented).",
            "startOffset": 34813,
            "title": "Discussion"
        },
        {
            "endOffset": 15615,
            "parents": [],
            "secId": "s0005",
            "sentence": "These analyses have focused on the hospital setting and impacts from single, theoretical vaccine products.",
            "startOffset": 15509,
            "title": "Introduction"
        },
        {
            "endOffset": 25838,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "We generated the lowest estimate by combining the 2.5 percentile values for MA-RSVi rates, lowest efficacy and uptake, and shortest duration, for each product as inputs (Table 2).",
            "startOffset": 25659,
            "title": "Model inputs and sensitivity analysis"
        },
        {
            "endOffset": 37293,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Discussion"
                }
            ],
            "secId": "s0075",
            "sentence": "Our model provides decision makers with the ability to examine the impact of directly or indirectly immunizing infants against RSV infection with anticipated immunization products.",
            "startOffset": 37113,
            "title": "Conclusions"
        },
        {
            "endOffset": 18486,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "In the model, palivizumab is given starting at birth for those born during the season, and starting at the beginning of the next RSV season when births occur out-of-season (OoS) (Table 1).",
            "startOffset": 18298,
            "title": "Tool overview"
        },
        {
            "endOffset": 35198,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 35197,
                    "startOffset": 35193
                }
            },
            "secId": "s0070",
            "sentence": "Even Hogan et al. concluded from their transmission model that herd effects due to the maternal vaccine were modest and a simple cohort model would be a reliable alternative for estimating immunization impacts among infants [14].",
            "startOffset": 34969,
            "title": "Discussion"
        },
        {
            "endOffset": 38249,
            "parents": [],
            "secId": "ce.section_ttb_mrh_qjb",
            "sentence": "The findings and conclusions in the report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.",
            "startOffset": 38076,
            "title": "Declaration of interests:"
        },
        {
            "endOffset": 34308,
            "parents": [],
            "refoffsets": {
                "b0085": {
                    "endOffset": 34307,
                    "startOffset": 34303
                }
            },
            "secId": "s0070",
            "sentence": "For example, Regnier, using a decision tree model to examine a theoretical vaccine for protecting infants in the US from birth, also estimated a 25% reduction in hospitalizations, but with assumptions of 69% uptake, 50% efficacy, and a decaying exponential distribution for the duration of protection with a 12 month median length [17].",
            "startOffset": 33972,
            "title": "Discussion"
        },
        {
            "endOffset": 33380,
            "parents": [],
            "secId": "s0070",
            "sentence": "The difference between these results and our baseline results were negligible.",
            "startOffset": 33302,
            "title": "Discussion"
        },
        {
            "endOffset": 36758,
            "parents": [],
            "secId": "s0070",
            "sentence": "Any overestimation from this limitation, however, is negligible (in the US at least), since < 1% of births are affected.",
            "startOffset": 36638,
            "title": "Discussion"
        },
        {
            "endOffset": 31804,
            "parents": [],
            "secId": "s0070",
            "sentence": "This was especially pronounced in the outpatient clinic and ED settings, where the peak of incidence is beyond the 90 days of protection assumed for the maternal candidate.",
            "startOffset": 31632,
            "title": "Discussion"
        },
        {
            "endOffset": 33301,
            "parents": [],
            "secId": "s0070",
            "sentence": "We also examined the influence of the timing of maternal vaccine uptake, by altering the immunization schedule so that it optimized the proportion of infants to whom antibodies successfully transfer (S2).",
            "startOffset": 33097,
            "title": "Discussion"
        },
        {
            "endOffset": 30513,
            "parents": [],
            "secId": "s0070",
            "sentence": "These results indicate substantial RSV morbidity and associated healthcare utilization due to serious RSVi may be averted with new products under development.",
            "startOffset": 30355,
            "title": "Discussion"
        },
        {
            "endOffset": 17107,
            "parents": [],
            "secId": "s0005",
            "sentence": "RSV I2M evaluates the potential impact of these products on outpatient clinic visits, ED visits, and hospitalizations based on user-adjustable RSVi rates and seasonality, in conjunction with assumptions about product uptake and efficacy.",
            "startOffset": 16870,
            "title": "Introduction"
        },
        {
            "endOffset": 37532,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Discussion"
                }
            ],
            "secId": "s0075",
            "sentence": "The findings can be used in economic analyses to understand the direct costs and benefits of these strategies and others.",
            "startOffset": 37411,
            "title": "Conclusions"
        },
        {
            "endOffset": 28597,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "When results assuming 120 and 180 days of protection by the antibody candidate are compared, the estimated LRTI visits prevented differed by 3,080 in the hospital setting, 26,960 in the ED setting, and 79,070 in the outpatient clinic setting.",
            "startOffset": 28355,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 35568,
            "parents": [],
            "secId": "s0070",
            "sentence": "Estimates of immunization impact are restricted to the season in which they are given.",
            "startOffset": 35482,
            "title": "Discussion"
        },
        {
            "endOffset": 33971,
            "parents": [],
            "secId": "s0070",
            "sentence": "Our findings are also in line with previous studies examining the effect of a single type of vaccine with similar characteristics to products we examined.",
            "startOffset": 33817,
            "title": "Discussion"
        },
        {
            "endOffset": 17322,
            "parents": [],
            "secId": "s0005",
            "sentence": "Model outputs (visits with and without immunization for LRTI due to RSV) can assist policy-makers in the United States and other countries with developing economic analyses and recommendations for RSV immunization.",
            "startOffset": 17108,
            "title": "Introduction"
        },
        {
            "endOffset": 28122,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The relative influence of individual parameters on our estimates of prevented LRTI-associated visits varied by immunization strategy and healthcare setting.",
            "startOffset": 27966,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 30080,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "In the hospital setting, a one percentage point increase in antibody candidate uptake is associated with 128 to 329 prevented LRTIs, and 58 to 215 prevented LRTIs for the maternal vaccine candidate.",
            "startOffset": 29882,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 35892,
            "parents": [],
            "secId": "s0070",
            "sentence": "We also do not account for the possible protection of mothers against RSVi by the maternal vaccine candidate.",
            "startOffset": 35783,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X19313866",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "GRainisch@cdc.gov",
                "first": "Gabriel",
                "initial": "G.",
                "last": "Rainisch"
            },
            {
                "email": null,
                "first": "Bishwa",
                "initial": "B.",
                "last": "Adhikari"
            },
            {
                "email": null,
                "first": "Martin I.",
                "initial": "M.I.",
                "last": "Meltzer"
            },
            {
                "email": null,
                "first": "Gayle",
                "initial": "G.",
                "last": "Langley"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.10.023",
        "firstpage": "251",
        "issn": "0264410X",
        "keywords": [
            "Infants",
            "Maternal vaccination",
            "Model",
            "Passive immunization",
            "RSV",
            "United States"
        ],
        "lastpage": "257",
        "openaccess": "Full",
        "pub_year": 2020,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants"
    }
}